Varant Arzoumanian is an Oncology physician affiliated with University of Arkansas for Medical Sciences. OpenAlex indexes 7 publications with 517 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6801 Rogers Ave Ste 200
Fort Smith, AR 729034067
Telephone
479-274-5260Provider last certified this registry record 29 May 2026.
Industry payments
44 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20257 payments
- Merck Sharp & Dohme LLCProgram year20258 payments
- Daiichi Sankyo Inc.Program year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
27.1%Aromatase Inhibitor10.2%Letrozole78%Anastrozole12%Exemestane10%Part D≥118 patientsKinase inhibitor5.5%Imatinib Mesylate18%Tasigna14%Inlyta8%Calquence8%Bosulif7%Everolimus7%Kisqali7%Verzenio5%Ibrance5%Tafinlar4%Erlotinib Hcl4%Alecensa4%Jakafi3%Mekinist3%Cabometyx3%Part D<11 patients+ 11 more classes in this area
Metabolism & gastrointestinal
18.6%Serotonin-3 Receptor Antagonist8.3%Ondansetron Hcl59%Ondansetron Odt41%Part D≥96 patientsPotassium supplement4.4%Potassium Chloride94%Klor-Con M206%Part D<11 patients+ 6 more classes in this area
Nervous system
18%Opioid Agonist5.3%Oxycodone Hcl51%Morphine Sulfate Er25%Tramadol Hcl11%Oxycodone-Acetaminophen8%Hydromorphone Hcl4%Methadone Hcl3%Part D<11 patientsGabapentinoids4.1%Gabapentin75%Pregabalin25%Part D≥52 patients+ 7 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ORIGINAL ARTICLE Suppression of abnormal karyotype predicts superior survival in multiple myeloma2008
Similar KOLs
Other experts from the same institution or the same specialty.
Maurizio Zangari, MD
University of Arkansas for Medical Sciences
Everett Magann, MD
University of Arkansas for Medical Sciences
Analiz Rodriguez, MD, PhD
University of Arkansas for Medical Sciences
Jorge Saucedo, MD
University of Arkansas for Medical Sciences
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”